We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Chinese Firm Cited for Recordkeeping Violations, Inadequate Testing
Chinese Firm Cited for Recordkeeping Violations, Inadequate Testing
The FDA hit Tianjin-Jingye Fine Chemicals with a Form 483 for 14 violations, ranging from inappropriate re-injection and outdated stability research to lack of hand-washing facilities.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor